Cargando…
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression
Uterine serous carcinoma (USC) is the most aggressive form of endometrial cancer, with poor survival rates and high recurrence risk. Therefore, the purpose of this study was to identify therapeutic targets that could aid in the management of USC. By analyzing endometrial cancer samples from The Canc...
Autores principales: | Kwan, Suet-Ying, Au-Yeung, Chi-Lam, Yeung, Tsz-Lun, Rynne-Vidal, Angela, Wong, Kwong-Kwok, Risinger, John I., Lin, Hui-Kuan, Schmandt, Rosemarie E., Yates, Melinda S., Mok, Samuel C., Lu, Karen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016780/ https://www.ncbi.nlm.nih.gov/pubmed/31906456 http://dx.doi.org/10.3390/cancers12010118 |
Ejemplares similares
-
Overexpression of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in boys with cryptorchidism
por: Toliczenko-Bernatowicz, Dorota, et al.
Publicado: (2018) -
Pivotal Role of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) in Uterine Leiomyoma
por: Suzuki, Tomoo, et al.
Publicado: (2023) -
Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo
por: Zhang, Mingming, et al.
Publicado: (2014) -
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
por: Au Yeung, Chi Lam, et al.
Publicado: (2016) -
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation
por: Ummanni, Ramesh, et al.
Publicado: (2011)